Ortho-tag

Ortho-tag

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Ortho-tag is pioneering a novel in-body communication and biosensing platform for medical implants. Its core technology, Volume Conduction Technology (VCT), provides a wireless, battery-free alternative to traditional RFID, enabling data exchange, implant identification, and diagnostic monitoring while being MRI-compatible and secure. The company targets applications in orthopedics and beyond, including post-surgical infection detection, in-vivo data storage, and controlled drug release, positioning itself at the intersection of smart implants and digital health.

OrthopedicsPost-surgical MonitoringImplantable Devices

Technology Platform

Proprietary Volume Conduction Technology (VCT) enabling wireless, battery-free in-body communication and data exchange for medical implants. It uses the body's conductive tissues to transmit signals, avoiding interference from metal or external RF sources (MRI compatible).

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The shift towards value-based care and smart implants creates a massive opportunity for a secure, MRI-compatible communication platform.
Early detection of costly complications like implant infections represents a multi-billion-dollar addressable market in orthopedics alone, with expansion potential into cardiology, neurology, and diabetes devices.

Risk Factors

Key risks include the technical challenge of reliably validating the novel Volume Conduction Technology in humans, navigating complex FDA regulatory pathways for a new platform, and the commercial hurdle of convincing large, established implant manufacturers to adopt and integrate an unproven enabling technology.

Competitive Landscape

Competition includes traditional RFID-based implant tracking solutions (which have interference limitations) and proprietary systems from large medtech firms (e.g., for specific smart implants). Ortho-tag's key differentiator is its MRI-compatible, battery-free, and interference-immune VCT platform, which, if proven, could become a new standard for in-body communication.